NecstGen and ProteoNic report development of improved viral vectors through the application of premium 2G UNic™ technology

[ad_1] LEIDEN, the Netherlands, Sept. 19, 2023 /PRNewswire/ — Necstgen, a non-profit CDMO and ProteoNic, a leading provider of premium vector technology and services for efficient production of biologics, announce…

Lyme disease: Could a vaccine target tick vectors instead of humans?

[ad_1] There is still no vaccine for Lyme disease in humans although trials are ongoing to develop one, but new research shows a vaccine given to mice could influence the…